Biotech news
Americas
Coherus BioSciences has asked a court to dismiss patent infringement allegations brought against it by Amgen. 12 June 2017
Americas
Law firm Foley & Lardner has hired a new partner, Karen Mangasarian, to join its New York office. 9 June 2017
Americas
Two thirds of biotech claims challenged in inter partes reviews are directed to methods of treatment, said Brendan O’Malley, partner at Fitzpatrick Cella Harper & Scinto, at a recent industry conference. 8 June 2017
Pharma
UK-based law firm Appleyard Lees has appointed Barbara Fleck as a partner in its Cambridge office. 1 June 2017
Americas
The Procter & Gamble Company and biotech company Canfield Scientific have sued Quantificare, a company manufacturing imaging solutions for clinical trials and physicians, for patent infringement. 30 May 2017
Americas
Biogen has asked the US District Court for the Eastern District of California to dismiss a competition complaint filed by biotech company Ixchel Pharma. 26 May 2017
Africa
The World Intellectual Property Organization’s Re:Search has launched a new five-year guide to its activities in the fight against neglected tropical diseases, malaria and tuberculosis. 24 May 2017
Biotech
The UK Competition and Markets Authority has provisionally decided that Merck Sharp & Dohme operated an anti-competitive discount scheme for its drug Remicade. 24 May 2017
Americas
AbbVie has lost in an inter partes review (IPR) of its rheumatoid arthritis drug Humira. 19 May 2017
Americas
Amgen has set its sights on Coherus Biosciences, a biosimilar maker, for allegedly infringing a patent concerning a process for purifying proteins. 12 May 2017